Contributor Page
Ropes & Gray LLP
By Amanda Raad, Joanna Torode, Mair Williams
The UK Home Secretary, Amber Rudd, announced earlier this week that the UK Government plans to set up a new National Economic Crime Centre (NECC) to be hosted within the UK's National Crime Agency (NCA).
By Mark Barnes, David Peloquin
What are the legal implications of using social media and mobile applications in clinical trials and the recent developments impacting research fraud investigations?
By Ropes & Gray LLP's Digital Health Practice Group, Ropes & Gray’s LLP's FDA Regulatory Practice
These developments continue to build on the policies FDA has been developing in recent years to clarify the applicability of FDA regulatory requirements to digital health technologies.
By Ropes & Gray LLP's Anti-Corruption / International Risk Practice, Ropes & Gray LLP's Tax Practice Group, Ropes & Gray LLP's Tax Controversy Practice Group, Ropes & Gray LLP's Risk Mitigation & Management Model Group
International authorities have previously published similar blacklists, but most have struggled for credibility.
By Scott A. McKeown
As I have pointed out previously, the Board struggles to issue precedential decisions. This is because the Board (now approaching 300 judges) must reach a "sufficient majority" consensus...
By Ropes & Gray LLP's Executive Compensation & Employee Benefits Practice
Last month, the IRS provided guidance regarding the procedures it will use to propose and assess employer shared responsibility payments under the Affordable Care Act ("ACA").
By Richard Batchelder, Jr., Aaron Katz, Dennis Coleman, Heather Egan Sussman
The Tenth Amendment will likely win the day, and that will open the doors to legislation in states that recognize, like New Jersey, the revenue opportunities presented by appropriately regulated sports betting.
By Jeffrey J. Bushofsky, Laura Hoey, Jennifer S. Walker, Samuel Perrone
Civil actions alleging state-law claims premised on violations of Medicare's rules may turn on specific procedures outlined in the Medicare Act — which contains an express preemption provision — and its implementing regulations.
By Rohan Massey, Douglas Meal, Heather Egan Sussman, James DeGraw, Seth Harrington, Mark Szpak, Michelle Visser, Michele Goldman, Kevin J. Angle Esq, Joseph Santiesteban
On November 29, 2017, the Supreme Court heard oral argument in Carpenter v. United States. The Court's decision could have critical implications for companies operating in the digital economy...
By Ropes & Gray LLP's Tax-Exempt Organizations
On December 4, 2017, the IRS released a notice that describes proposed guidance the IRS and Treasury are considering with respect to donor advised funds
By Geoffrey M. Atkins, Brendan Hanifin, Karen Oddo, Ezra Geggel
In late October, a bipartisan coalition of lawmakers introduced legislation in both houses of Congress that would impose sanctions targeting certain members of Myanmar's military.
By Scott A. McKeown
Previously I explained that the 7th amendment argument in Oil States and the 11th amendment argument for sovereign immunity from the PTAB are both tied to the same basic, threshold premise —
By Ropes & Gray LLP's Tax Practice Group
A comparison of the most significant provisions of the House and Senate bills can be found here.
By Nicholas Berg, James Dowden, Alexandre Rene, Caleb Dulis
Recent statements by the Co-Director of the SEC's Enforcement Division indicate that the SEC has not emphasized individual prosecutions to the same degree as DOJ.
By John Chesley, Ira Parghi, Elizabeth M. Whitkin
On Oct. 9, 2017, California Gov. Jerry Brown signed into law SB-17, a law intended to foster transparency in connection with drug pricing and its impact on insurance costs.
Contributor's Topics